Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Alexza Pharmaceuticals Inc. | d79869e8vk.htm |
| EX-10.2 - EX-10.2 - Alexza Pharmaceuticals Inc. | d79869exv10w2.htm |
| EX-10.3 - EX-10.3 - Alexza Pharmaceuticals Inc. | d79869exv10w3.htm |
| EX-10.4 - EX-10.4 - Alexza Pharmaceuticals Inc. | d79869exv10w4.htm |
Exhibit 10.1
| Name and Title | Stock Option Awards | |
Thomas B. King President and Chief Executive Officer |
213,143 | |
James V. Cassella, Ph.D. Senior Vice President, Research and Development |
104,258 | |
August J. Moretti Senior Vice President, Chief Financial Officer, General Counsel and Secretary |
75,746 | |
Michael J. Simms Senior Vice President, Operations and Quality |
61,076 |